Chris Major is the Founding Partner of BioProcess360 Partners, a venture capital firm in Newcastle upon Tyne. See sector focus and contact routes.
Chris Major is the Founding Partner of BioProcess360 Partners, a venture capital firm in Newcastle upon Tyne, where he leverages prior experience leading the Purolite Bioprocessing division’s acquisition by Ecolab and investing through Run Partners. His firm’s investment thesis targets emerging bioprocessing tools and technologies, focusing exclusively on the bioprocessing sector—particularly downstream purification—without geographic restriction beyond supporting global biopharma advancement. The dedicated Life Sciences fund provides financial support and industry expertise to help companies overcome R&D obstacles, though specific check sizes and lead/follow behavior are not publicly disclosed. Notable portfolio details are limited in available sources, with no named companies explicitly confirmed in the search results. Major emphasizes that hands-on industry experience is critical for navigating growth challenges in bioprocessing, distinguishing his firm by offering operational support alongside capital. He has publicly articulated this viewpoint in a LinkedIn Pulse article titled “Insights from a Bioprocessing Investor: Identifying the Focus and Gap,” where he
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Newcastle upon Tyne.
Investors like Chris Major · Full investor directory · Investor access · Company funding database